Abnormalities of B cell stimulatory factors (BSF) produced by T cells and B cell response to BSF from patients with systemic lupus erythematosus (SLE)

In the present study, we demonstrated that peripheral blood T lymphocytes from active patients with systemic lupus erythematosus (SLE) spontaneously produced B cell stimulatory factor (BSF) after 2 days' culture. The BSF contained B cell growth factor (BCGF) and B cell differentiation factor (BCDF) activities. These BCGF and BCDF activities spontaneously produced by T cells from active SLE patients were almost as potent as that of PHA-stimulated T cells from normal individuals and inactive SLE patients. Furthermore, B lymphocytes from active patients with SLE proliferated or secreted IgG antibody in response to BCGF or BCDF alone in the absence of anti-IgM or SAC-stimulation. Particulary, B cells from active SLE patients produced marked IgG in response to BCDF. The activity of BCGF or BCDF spontaneously secreted by T cells from active SLE patients correlated inversely with the magnitude of responsiveness of B cells in response to BCGF or BCDF.Accordingly, the mechanism for B cell activation in patients with SLE seems to be heterogeneous. Such abnormal response to BSF and/or overproduction of BSF ultimately lead to polyclonal and even autoantigen-specific B cell expansion which result in the production of autoantibodies.

[1]  T. Hirano,et al.  Human helper T cell factor(s). III. Characterization of B cell differentiation factor I (BCDF I). , 1984, Journal of immunology.

[2]  R. Balderas,et al.  B cell dependence on and response to accessory signals in murine lupus strains , 1983, The Journal of experimental medicine.

[3]  R. Kofler,et al.  Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype , 1983, The Journal of experimental medicine.

[4]  C. Morimoto,et al.  In Vitro Immune Response of SLE Lymphocytes , 1982, Scandinavian journal of immunology.

[5]  C. Y. Wang,et al.  Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity , 1982, The Journal of experimental medicine.

[6]  A. Fauci,et al.  Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation. , 1982, Journal of immunology.

[7]  W. Paul,et al.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2 , 1982, The Journal of experimental medicine.

[8]  P. Marrack,et al.  B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor , 1981, The Journal of experimental medicine.

[9]  S. Swain,et al.  Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Lipsky,et al.  Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. , 1979, Clinical and experimental immunology.

[11]  B. Haynes,et al.  Immunoregulatory aberrations in systemic lupus erythematosus. , 1978, Journal of immunology.

[12]  H. Inoue,et al.  Triggering mechanism of B lymphocytes. II. Induction of ornithine decarboxylase in B cells by anti-immunoglobulin and enhancing soluble factor. , 1975, Journal of immunology.

[13]  T. Kishimoto,et al.  Triggering mechanism of B lymphocytes. I. Effect of anti-immunoglobulin and enhancing soluble factor on differentiation and proliferation of B cells. , 1975, Journal of immunology.